JonathanS.DosikMD

Dermatology • Glen Rock, NJ

Physician

Join to view full profile

Dr. Dosik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dosik's full profile

Already have an account?

Office
348 S Maple Ave
Glen Rock, NJ 07452
Phone+1 201-652-6060

Fax+1 201-652-1882

Education & Training

NYU Grossman School of MedicineResidency, Dermatology, 1997 - 2000
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1996 - 1997
New York University School of MedicineClass of 1996

Certifications & Licensure

NJ State Medical License 2000 - 2025
NY State Medical License 1997 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers Start of enrollment: 2010 Jul 01
Completed
Phase 2
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects Start of enrollment: 2011 Feb 01
Completed
Phase 1
24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness Start of enrollment: 2012 Jul 01
Unknown status
Not Applicable
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion Start of enrollment: 2014 Jan 01
Completed
Phase 1
Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging Start of enrollment: 2017 Oct 01
Withdrawn
Not Applicable
Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream Start of enrollment: 2019 Feb 13
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

A 6-month, Multi-center, Double-blind, Controlled Study to Evaluate the Effect of a Biofilm Disrupting Acne Cream on Mild-to-Moderate Facial Acne in Female Volunteer S...
Allyson Marshall-Hudson, Michael Tuley, Maureen Damstra, Jonathan S Dosik, Matthew F Myntti
The Journal of Clinical and Aesthetic Dermatology. 2023-04-01
2 citations
Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers.
Jonathan Dosik, David L Cutler, Jane Fang, Laura Padullés
JID Innovations. 2023-03-01
2 citations
Skin Irritation and Sensitization Potential of Fixed-Dose Combination of Diclofenac 1% and Menthol 3% Topical Gel: Results of Two Phase I Patch Studies.
Dongzhou Jeffery Liu, Agron Collaku, Jonathan S. Dosik
Drug Research. 2016-11-25

Professional Memberships

American Academy of Dermatology - AAD
Fellow